Personalized messaging with clinicians, ongoing medication management, and a to help maintain weight loss after discontinuing medication
Future studies will need to clarify whether any signal differs by menopausal status, endocrine therapy exposure, obesity phenotype, tumor subtype, or duration and timing of GLP-1 receptor agonist use
Our work confirms this effect, and also demonstrates that SCFA-stimulated PYY release is attenuated in the same model
Additionally, the crossover design improves statistical efficiency, as the variance between participants is reduced, allowing for a smaller sample size while maintaining the ability to detect significant effects
Its important to avoid unqualified providers or attempting to administer injections yourself unless youre properly trained